Progyny Statistics
Total Valuation
Progyny has a market cap or net worth of $2.24 billion. The enterprise value is $1.93 billion.
| Market Cap | 2.24B |
| Enterprise Value | 1.93B |
Important Dates
The last earnings date was Thursday, November 6, 2025, after market close.
| Earnings Date | Nov 6, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Progyny has 86.21 million shares outstanding. The number of shares has decreased by -6.22% in one year.
| Current Share Class | 86.21M |
| Shares Outstanding | 86.21M |
| Shares Change (YoY) | -6.22% |
| Shares Change (QoQ) | +0.66% |
| Owned by Insiders (%) | 1.76% |
| Owned by Institutions (%) | 96.85% |
| Float | 79.57M |
Valuation Ratios
The trailing PE ratio is 42.14 and the forward PE ratio is 13.86. Progyny's PEG ratio is 1.27.
| PE Ratio | 42.14 |
| Forward PE | 13.86 |
| PS Ratio | 1.79 |
| Forward PS | 1.61 |
| PB Ratio | 3.97 |
| P/TBV Ratio | 4.20 |
| P/FCF Ratio | 11.59 |
| P/OCF Ratio | 10.77 |
| PEG Ratio | 1.27 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 21.32, with an EV/FCF ratio of 9.95.
| EV / Earnings | 34.04 |
| EV / Sales | 1.52 |
| EV / EBITDA | 21.32 |
| EV / EBIT | 22.43 |
| EV / FCF | 9.95 |
Financial Position
The company has a current ratio of 2.96, with a Debt / Equity ratio of 0.05.
| Current Ratio | 2.96 |
| Quick Ratio | 2.84 |
| Debt / Equity | 0.05 |
| Debt / EBITDA | 0.30 |
| Debt / FCF | 0.15 |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 11.37% and return on invested capital (ROIC) is 10.29%.
| Return on Equity (ROE) | 11.37% |
| Return on Assets (ROA) | 7.37% |
| Return on Invested Capital (ROIC) | 10.29% |
| Return on Capital Employed (ROCE) | 14.68% |
| Revenue Per Employee | $1.87M |
| Profits Per Employee | $83,187 |
| Employee Count | 680 |
| Asset Turnover | 1.74 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, Progyny has paid $38.67 million in taxes.
| Income Tax | 38.67M |
| Effective Tax Rate | 40.60% |
Stock Price Statistics
The stock price has increased by +78.03% in the last 52 weeks. The beta is 0.97, so Progyny's price volatility has been similar to the market average.
| Beta (5Y) | 0.97 |
| 52-Week Price Change | +78.03% |
| 50-Day Moving Average | 22.59 |
| 200-Day Moving Average | 22.26 |
| Relative Strength Index (RSI) | 59.95 |
| Average Volume (20 Days) | 1,376,268 |
Short Selling Information
The latest short interest is 5.32 million, so 6.17% of the outstanding shares have been sold short.
| Short Interest | 5.32M |
| Short Previous Month | 6.68M |
| Short % of Shares Out | 6.17% |
| Short % of Float | 6.68% |
| Short Ratio (days to cover) | 3.00 |
Income Statement
In the last 12 months, Progyny had revenue of $1.27 billion and earned $56.57 million in profits. Earnings per share was $0.62.
| Revenue | 1.27B |
| Gross Profit | 291.04M |
| Operating Income | 85.84M |
| Pretax Income | 95.24M |
| Net Income | 56.57M |
| EBITDA | 90.29M |
| EBIT | 85.84M |
| Earnings Per Share (EPS) | $0.62 |
Balance Sheet
The company has $345.21 million in cash and $28.15 million in debt, giving a net cash position of $317.06 million or $3.68 per share.
| Cash & Cash Equivalents | 345.21M |
| Total Debt | 28.15M |
| Net Cash | 317.06M |
| Net Cash Per Share | $3.68 |
| Equity (Book Value) | 560.00M |
| Book Value Per Share | 6.55 |
| Working Capital | 411.52M |
Cash Flow
In the last 12 months, operating cash flow was $208.15 million and capital expenditures -$14.69 million, giving a free cash flow of $193.46 million.
| Operating Cash Flow | 208.15M |
| Capital Expenditures | -14.69M |
| Free Cash Flow | 193.46M |
| FCF Per Share | $2.24 |
Margins
Gross margin is 22.94%, with operating and profit margins of 6.77% and 4.46%.
| Gross Margin | 22.94% |
| Operating Margin | 6.77% |
| Pretax Margin | 7.51% |
| Profit Margin | 4.46% |
| EBITDA Margin | 7.12% |
| EBIT Margin | 6.77% |
| FCF Margin | 15.25% |
Dividends & Yields
Progyny does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 6.22% |
| Shareholder Yield | 6.22% |
| Earnings Yield | 2.52% |
| FCF Yield | 8.63% |
Analyst Forecast
The average price target for Progyny is $27.44, which is 5.50% higher than the current price. The consensus rating is "Buy".
| Price Target | $27.44 |
| Price Target Difference | 5.50% |
| Analyst Consensus | Buy |
| Analyst Count | 9 |
| Revenue Growth Forecast (5Y) | 8.63% |
| EPS Growth Forecast (5Y) | 28.02% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Progyny has an Altman Z-Score of 7.38 and a Piotroski F-Score of 7.
| Altman Z-Score | 7.38 |
| Piotroski F-Score | 7 |